High yield, cut rate — coverage unproven on trailing earnings. A 4.29% yield that comes with a warning label: $0.35 a quarter is half the $0.70 paid through August 2025, cut as chemicals earnings fell, and trailing earnings are negative, so no trailing payout ratio is meaningful. Q3 2026 brought GAAP net income of $525 million and $0.62 of GAAP EPS on $11.3 billion of sales — one quarter covering the rate, not yet a recovery.
Key risk: Chemicals-cycle exposure — polyethylene, silicones, and coatings pricing swings with industrial demand and energy costs, and the last cycle forced the dividend cut this card is still priced around.
Changes if: Trailing earnings turn positive and cover the $1.40 indicated rate, or the $0.35 rate is cut again. A second cut would end the research case outright.
- ✗Payout-coverage check: No meaningful trailing payout — trailing earnings are negative, so the $1.40 indicated dividend is covered only if quarterly earnings like Q3 2026 ($0.62 GAAP EPS) repeat.
- !Yield check: 4.29% indicated — $0.35/qtr × 4 at the $32.61 close on Oct. 23, 2026. Real cash dividend, but a post-cut rate, not a growing one.
- ✗Dividend growth check: Cut, not grown: $0.70 a quarter through August 2025, then $0.35 from September 2025 onward — a 50% reduction.
What this grade doesn't say: It screens the dividend only — covered, real, compounding. It says nothing about valuation or price: a well-covered payer can still be overpriced, and its price can still fall.